| Revenue | 37.33 | - | - | - |
| Cost of Revenue | 49.01 | - | - | - |
| Gross Profit | -11.68 | - | - | - |
| Selling, General & Admin | 175.88 | 25.15 | 10.04 | 9.04 |
| Research & Development | 24.43 | 15.9 | 0.73 | 1.86 |
| Operating Expenses | 200.31 | 41.05 | 10.77 | 10.9 |
| Operating Income | -211.99 | -41.05 | -10.77 | -10.9 |
| Interest Expense | -4.53 | -0.08 | -1.98 | -1.33 |
| Interest & Investment Income | 1.28 | 0.04 | - | - |
| Other Non Operating Income (Expenses) | -25.39 | -4.19 | -0.32 | -0.41 |
| EBT Excluding Unusual Items | -240.63 | -45.27 | -13.07 | -12.65 |
| Gain (Loss) on Sale of Investments | - | -2.97 | - | - |
| Gain (Loss) on Sale of Assets | 0.09 | - | - | - |
| Asset Writedown | -3.18 | - | - | - |
| Legal Settlements | -22.97 | - | - | - |
| Pretax Income | -266.7 | -48.24 | -13.07 | -12.65 |
| Earnings From Continuing Operations | -266.7 | -48.24 | -13.07 | -12.65 |
| Minority Interest in Earnings | 1.4 | 0.54 | 0.68 | 0.74 |
| Net Income | -265.29 | -47.71 | -12.39 | -11.91 |
| Net Income to Common | -265.29 | -47.71 | -12.39 | -11.91 |
| Shares Outstanding (Basic) | 287 | 246 | 240 | 240 |
| Shares Outstanding (Diluted) | 287 | 246 | 240 | 240 |
| Shares Change (YoY) | 16.64% | 2.44% | - | - |
| EPS (Basic) | -0.92 | -0.19 | -0.05 | -0.05 |
| EPS (Diluted) | -0.92 | -0.19 | -0.05 | -0.05 |
| Free Cash Flow | -143.56 | -179.22 | -6.11 | -0.66 |
| Free Cash Flow Per Share | -0.50 | -0.73 | -0.03 | -0.00 |
| Gross Margin | -31.29% | - | - | - |
| Operating Margin | -567.85% | - | - | - |
| Profit Margin | -710.62% | - | - | - |
| Free Cash Flow Margin | -384.53% | - | - | - |
| EBITDA | -211.19 | -41 | -10.75 | -10.86 |
| D&A For EBITDA | 0.8 | 0.05 | 0.02 | 0.04 |
| EBIT | -211.99 | -41.05 | -10.77 | -10.9 |